| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-06 |